Valiant Organics Limited — PPTs, 20-08-2025: Investor Presentation

Valiant Organics reported strong Q1 FY26 results. Operational revenue climbed 21.7% year-on-year to INR 204.4 Cr. EBITDA surged 58% Y-o-Y to INR 24.8 Cr, with margins expanding significantly to 12.13%. Profit After Tax (PAT) reached INR 8.2 Cr, an impressive turnaround from a loss last year, with EPS at INR 2.93/share. Growth was fueled by higher sales volumes, better realizations, and an improved product mix. Hydrogenation chemistry was a key revenue contributor at 53%.

The company's strategy focuses on high-demand, low-supply specialty chemicals, often import substitutes. Strengths include a diverse product range, integrated manufacturing, and strategically located plants. Q1 performance showed improved cost efficiency and strong operational execution, driving margin expansion. While Q1 highlights operational strength, specific forward-looking plans or capex details were not provided.